Resource Center
Browse industry research articles, publications, and other important resources.
-
browse
By Topic
By Disease Area
-
Insurance Coverage for Genomic Tests
-
Paying for Cures: Perspectives on Solutions to the “Affordability Issue”
-
Choosing Important Health Outcomes for Comparative Effectiveness Research: An updated systematic review and involvement of low and middle income countries.
-
Stakeholder Perspectives Regarding Alternate Approaches to Informed Consent for CER
-
Core Clinical Data Elements for Cancer Genomic Repositories: A Multi-Stakeholder Consensus
-
Core Outcome Set-STAndards for Development: The COS-STAD recommendations
-
Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains.
-
CAP Accreditation Standards and Proficiency Testing for Diagnostic Next Generation Sequencing
-
Genomic Technologies Forum Meeting Briefing
-
RWE Decoder: A Practical Tool for Assessing Relevance and Rigor of Real World Evidence
-
Best Practices for the Design, Implementation, Analysis, and Reporting of Oncology Trials with High Rates of Treatment Switching
-
Methods for Evaluating the Comparative Effectiveness of Interventions for Obesity and Overweight
-
Webinar: Initial Medical Policy and Model Coverage Guidelines
-
Evaluating the comparative effectiveness of treatment sequences in oncology: a new approach
-
Next Gen Sequencing in Clinical Oncology: Phase 2 Overview
-
Initial Medical Policy and Model Coverage Guidelines for Clinical NGS in Oncology
-
Highlights of the 2015 Annual GPC Meeting
-
Payer perspective on future acceptability of comparative effectiveness and relative effectiveness research (2015)
-
Medical and pharmacy coverage decision making at the population level (2014)
-
Recommendations for Comparing Therapeutic Sequences for Patients with Breast, Kidney, and Other Advanced and Metastatic Cancers (Aug 2015)
-
Understanding the role and evidence expectations of health technology assessment and coverage/payer bodies: What are they looking for, and how and why does this differ from what regulators require? (2014)
-
The views of quality improvement professionals and comparative effectiveness researchers on ethics, IRBs, and oversight (2015)
-
Green Park Collaborative Annual Progress Report 2015
-
Futurescapes: Evidence expectations in Europe for comparative effectiveness research for drugs in 2020 (2015)
-
Futurescapes: Evidence expectations in the USA for comparative effectiveness research for drugs in 2020 (2015)
-
The future of comparative effectiveness and relative efficacy of drugs: an international perspective (2015)
-
From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients (2015)
-
Reimbursing NGS Testing. Clinical OMICs – Molecular diagnostics in personalized medicine (2015)
-
Demonstrating the Clinical Utility of Next Generation Sequencing in Clinical Oncology
-
What can comparative effectiveness research contribute to integrative health in international perspective? (2014)
-
A Multi-stakeholder Agenda to Advance Enhanced Recovery for U.S. Surgical Patients
-
Summary & Slides: Hepatitis C Drugs - Evidence to Demonstrate Effectiveness and Value
-
exCERpts July 2014
-
Enhanced Recovery Meeting Summary
-
Accelerated access to innovative medicines for patients in need (2014)
-
Recommendations for Late Phase Drug Studies in Type 2 Diabetes (July 2014)
-
EGD Process Document (June 2014)
-
exCERpts May 2014
-
Green Park Collaborative-USA Annual Progress Report 2013-2014
-
The Current Drug Development Paradigm: Responding to US and European Demands for Evidence of Comparative Effectiveness and Relative Effectiveness
-
Debating the Evidence of Pharmacogenetic Testing
-
exCERpts February 2014
-
Green Park Collaborative-USA Overview (2014)
-
Stakeholder Defined Research: Designing Studies that reflect the perspectives of patients, clinicians and payers (February 2014)
-
Payer Perspectives on Improving Usability of Effective Health Care Products (February 2014)
-
PCORnet PPRN Partner Meeting (January 2014)
-
PCORnet Kickoff Meeting (January 2014)
-
Early Pharmaceutical Pragmatic Clinical Trials (December 2013)
-
Endocrine Metabolic Consortium Overview (Nov 2013)
-
COMET Initiative: Core outcome measures in effectiveness trials (Nov 2013)
-
Panel Discussion: What are the Evidence Gaps Affecting Clinical Use of Next Generation Sequencing Tests in Oncology?
-
Oncology Consortium Update
-
Progress Update: Endocrine-Metabolic Consortium
-
GPC-USA Annual Meeting Presentations (Nov 2013)
-
Electronic Consent: A Discussion of the eConsent Experience, Ethical and Regulatory Considerations, and the IRB Review Process
-
Oncology Overview (2013)
-
exCERpts November 2013
-
Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes? (Oct 2013)
-
Bariatric Surgery CED
-
Methodological recommendations for comparative research on the treatment of chronic wounds.
-
Medicare Policy on Bariatric Surgery: Decision Making in the Face of Uncertainty (Sept 2013)
-
Recommendations for the Design of Phase 3 Pharmaceutical Trials that are more Informative for Patients, Clinicians, and Payers (Sept 2013)
-
Ethics and Informed Consent for Comparative Effectiveness Research with Prospective Electronic Clinical Data (August 2013)
-
Break a Vicious Cycle (July 2013)
-
NIH Collaboratory Stakeholder Engagement Core (July 2013)
-
Encouraging Value-based Insurance Designs in State Health Insurance Exchanges (July 2013)
-
Performance-based Risk-sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-based Risk-sharing Arrangements Task Force. (July 2013)
-
exCERpts July 2013
-
EGD Overview (2014)
-
Establishing Work Priorities for GPC-USA (May 2013)
-
Green Park Collaborative - USA: Governance Establishment Discussion (May 2013)
-
Evaluation of Clinical Validity and Clinical Utility of Actionable Molecular Diagnostics in Adult Oncology (May 2013)
-
Development of an EGD for Patient Reported Outcomes in Oncology (May 2013)
-
An Overview of the Green Park Collaborative (May 2013)
-
Delivering Value in Healthcare: A Multi-Stakeholder Vision (May 2013)
-
HTAi Policy Forum: Points of Relevance to GPC-USA (May 2013)
-
Evaluation of Clinical Validity and Utility of Actionable Molecular Diagnostic Tests in Adult Oncology (May 2013)
-
Value-of-Information Analysis Within a Stakeholder-driven Research Prioritization Process in a US Setting: An Application in Cancer Genomics (April 2013)
-
Green Park Collaborative Evaluation Report (April 2013)
-
exCERpts April 2013
-
Design of Clinical Studies of Pharmacologic Therapies for Alzheimer’s Disease (April 2013)
-
Regulatory and Reimbursement Innovation (March 2013)
-
Recommendations From the EGAPP Working Group: Does Genomic Profiling to Assess Type 2 Diabetes Risk Improve Health Outcomes? (March 2014)
-
Recommendations from the EGAPP Working Group: Can Testing of Tumor Tissue for Mutations in EGFR Pathway Downstream Effector Genes in Patients with Metastatic Colorectal Cancer Improve Health Outcomes by Guiding Decisions Regarding anti-EGFR Therapy? (Feb 2013)
-
Getting Our Priorities Straight: a Novel Framework for Stakeholder-informed Prioritization of Cancer Genomics Research (Feb 2013)
-
Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP methods update (January 2013)
-
An Ethics Framework for a Learning Health Care System: A Departure from Traditional Research Ethics and Clinical Ethics (January 2013)
-
The Research-treatment Distinction: A Problematic Approach for Determining Which Activities Should have Ethical Oversight (January 2013)
-
Stakeholder Participation in Comparative Effectiveness Research: Defining a Framework for Effective Engagement (December 2012)
-
Incorporating Stakeholder Perspectives in Developing a Translation Table Framework for Comparative Effectiveness Research (December 2012)
-
Stakeholder Assessment of the Evidence for Cancer Genomic Tests: Insights from Three Case Studies (December 2012)
-
Recommendations for Incorporating Patient-reported Outcomes into Clinical Comparative Effectiveness Research in Adult Oncology (December 2012)
-
Improving the Efficiency and Effectiveness of Pragmatic Clinical Trials in Older Adults in the United States.
-
Methodological Recommendations for Comparative Effectiveness Research on the Treatment of Chronic Wounds (October 2012)
-
Effectiveness Guidance Document (EGD) for Acupuncture Research - a Consensus Document for Conducting Trials (Sept 2012)
-
Proposed Recommendations for Designing Clinical Trials for “New Indications” of Approved Oncology Drugs for Treatment of Late Stage Disease (September 2012)
-
Stakeholder Engagement in Comparative Effectiveness Research: How Will We Measure Success? (Sept 2012)
-
Improving Comparative Effectiveness Research: New Methodological Standards Focus on Quality and Relevance of Research to Patients (August 2012)
-
Research on the Treatment of Atrial Fibrillation (July 2012)